Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Dexamethasone × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 57 Recurrence 8 Burkitt Lymphoma 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Immunoglobulin Light-chain Amyloidosis 7 Neoplasms 6 Prostatic Neoplasms 5 Leukemia, Biphenotypic, Acute 4 Paraproteinemias 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 beta-Thalassemia 1 Vomiting 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Supratentorial Neoplasms 1 Smoldering Multiple Myeloma 1 Renal Insufficiency 1 Rectal Neoplasms 1 Radiation Pneumonitis 1

Interventions

Rituximab 11 Cyclophosphamide 7 Lenalidomide 5 zanubrutinib 4 venetoclax 4 Vincristine 4 orelabrutinib 3 fludarabine 3 Prednisone 3 Doxorubicin 3 CT-P10 3 obinutuzumab 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Specimen Handling 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 voruciclib 1 treosulfan 1 tislelizumab 1 prednylidene 1 pirtobrutinib 1 pembrolizumab 1 ixazomib 1 ibrutinib 1 glofitamab 1 deltacortene 1 cc-486 1 Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡